AIM4
AIM4 is a compound that can inhibit the aggregation of TDP-43. AIM4 has good biocompatibility and anti-inflammatory activity. AIM4 can be used in the research of diseases such as amyotrophic lateral sclerosis[1].
Product Specifications
CAS Number
[1841140-38-2]
UNSPSC
12352005
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Purity
99.07
Smiles
O=C(CN1C=C[N+](CC2=CC=CC3=CC4=CC=CC(C[N+]5=CN(CC(O)=O)C=C5)=C4N=C23)=C1)O.[Br-].[Br-]
Molecular Formula
C25H23Br2N5O4
Molecular Weight
617.29
References & Citations
[1]Revi N, et al. Acridine Benzimidazolium Derivatives Induced Protective Microglia Polarization and In Silico TDP-43 Interaction─Potential Implications for Amyotrophic Lateral Sclerosis. ACS Chem Neurosci. 2025 Mar 19;16 (6) :1103-1116.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV759669 1.0 µg DNA
CYCSP40 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details O2970-80B-APC 200 µL
OASIS, CT (Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, cAMP-responsive Element-binding Protein 3-like Protein 1, Old Astrocyte Specifically-induced Substance, Processed Cyclic AMP-responsive Element-binding Protein 3-like Protein 1, CREB3L1, PSEC0238) (APC) discontinued
Sign In for Pricing
View Details 